Form 4: Johnson & Johnson Executive Timothy Schmid Reports Stock Option and Restricted Share Unit Awards

Sentiment:

SEC Form 4 Filing


EVP Timothy Schmid reports the acquisition of stock options and restricted share units in Johnson & Johnson under the company's Long-Term Incentive Plan.

Summary

  • Timothy Schmid, an Executive Vice President at Johnson & Johnson, filed a Form 4 to report changes in beneficial ownership.
  • On February 15, 2025, Schmid was awarded 49,878 employee stock options with an exercise price of $156.15.
  • These options vest in three equal annual installments starting on February 15, 2026, and expire on February 15, 2035.
  • Schmid also received 3,077 restricted share units (RSUs) that vest in three equal annual installments beginning on February 15, 2026.
  • These RSUs convert into shares of Johnson & Johnson common stock on a one-for-one basis upon vesting.
  • Following these transactions, Schmid directly owns 49,878 employee stock options and 3,077 restricted share units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects standard executive compensation practices, indicating confidence in the executive and the company's future performance.

Positives

  • The granting of stock options and RSUs aligns executive compensation with the company's long-term performance.
  • The vesting schedule encourages the executive to remain with the company for at least three years.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options and RSUs.

Industry Context

Stock options and RSUs are common components of executive compensation packages in publicly traded companies like Johnson & Johnson, aligning executive interests with shareholder value and incentivizing long-term performance.

Comparison to Industry Standards

  • Granting stock options and RSUs is a standard practice among large, publicly traded companies like Johnson & Johnson to incentivize executives.
  • Companies such as Pfizer (PFE) and Merck (MRK) also utilize similar long-term incentive plans for their executives.
  • The vesting schedules, typically three to four years, are also in line with industry norms to ensure executive retention and commitment to long-term growth.

Stakeholder Impact

  • The granting of stock options and RSUs can positively impact shareholders by aligning executive interests with long-term company performance.
  • Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
02/15/2025Date of stock option and RSU awards.
02/15/2026First vesting date for both stock options and RSUs.
02/15/2035Expiration date for the stock options.
02/19/2025Date of Form 4 filing.

Keywords

Form 4, Johnson & Johnson, Stock Options, Restricted Share Units, Executive Compensation, Beneficial Ownership, JNJ, Timothy Schmid

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.